Blood test and AI team up to sniff out lung cancer early in smokers

NCT ID NCT07552584

Recruiting now Diagnosis Sponsor: Vejle Hospital Source: ClinicalTrials.gov ↗

First seen Apr 29, 2026 · Last updated May 25, 2026 · Updated 4 times

Summary

This study is testing whether a blood test, combined with artificial intelligence (AI), can help find lung cancer early in people with COPD who are current or former smokers. About 1,000 participants will give a blood sample, and the AI will analyze it to see who has a higher risk of lung cancer. Those at higher risk will then get a low-dose CT scan to check for cancer. The goal is to see if this approach is practical and safe for catching lung cancer sooner.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER (DIAGNOSIS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

General practices, Vejle area
RECRUITING

Vejle, Denmark

Contact Phone: •••-•••-•••• Email: •••••@•••••
Lillebaelt Hospital Vejle, University Hospital of Southern Denmark
RECRUITING

Vejle, 7100, Denmark

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

LUNG CANCER (DIAGNOSIS)